# New Imaging Biomarkers Predictive of MA Progression

> **NCT05939362** · NA · RECRUITING · sponsor: **Poitiers University Hospital** · enrollment: 80 (estimated)

## Conditions studied

- Alzheimer Disease
- Magnetic Resonance Spectroscopy
- Ultra High Field 7T
- Progression of Disease
- MR Biomarkers

## Interventions

- **OTHER:** MRI follow-up

## Key facts

- **NCT ID:** NCT05939362
- **Lead sponsor:** Poitiers University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-02
- **Primary completion:** 2027-10-02
- **Final completion:** 2028-01-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05939362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05939362, "New Imaging Biomarkers Predictive of MA Progression". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05939362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*